TREATMENT OF VULVOVAGINAL CANDIDIASIS AND NEW THERAPEUTIC PERSPECTIVES: A NARRATIVE REVIEW

Abstract

Introduction: The vulvovaginal candidiasis (VVC) is an infectious process of lower genitourinary tract and it´s caused by Candida fungus. In Brazil, VVC is the second most common diagnosis and it has turned into a concern to health professionals because of its growing number of cases of recurrence. The difficulty in the therapeutic approach of VVC points to the importance of the development of studies that address the current therapies used for this infection and its limitations, considering the professionals to develop a critical view on the subject and seek changes in the clinical management. Objective: This study aims to describe the current panorama of the VVC treatment and its new therapeutic perspectives. Methodological Strategy: It was developed a literature review including article in portuguese and english language that discussed the issue of current treatments for VVC and possible new therapeutic. Results: It is noted that VVC cases, especially recurrent, have displayed some level of resistance to current drug treatment and because of that there is an increasing search for new types of therapeutic interventions. Among the new possibilities, the Light Emitting Diode (LED) in the blue color of 405 nm is a possible treatment mode however it´s necessary more studies that can prove its effectiveness. Conclusion: The present antifungal therapy have shown limitations, mainly in cases of recurrence and this strengthens the need to search for new therapeutic modalities which are able to treat infectious processes by inhibiting microorganism resistance mechanisms.